Announcement • Jul 30
CleanSpace Holdings Limited to Report Fiscal Year 2026 Results on Aug 28, 2026 CleanSpace Holdings Limited announced that they will report fiscal year 2026 results on Aug 28, 2026 Announcement • Feb 02
CleanSpace Holdings Limited to Report Q2, 2026 Results on Feb 26, 2026 CleanSpace Holdings Limited announced that they will report Q2, 2026 results on Feb 26, 2026 Reported Earnings • Aug 27
Full year 2025 earnings released: AU$0.006 loss per share (vs AU$0.04 loss in FY 2024) Full year 2025 results: AU$0.006 loss per share (improved from AU$0.04 loss in FY 2024). Revenue: AU$19.8m (up 26% from FY 2024). Net loss: AU$478.3k (loss narrowed 85% from FY 2024). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Medical Equipment industry in Australia. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Breakeven Date Change • Aug 18
Forecast to breakeven in 2026 The analyst covering CleanSpace Holdings expects the company to break even for the first time. New forecast suggests losses will reduce by 87% to 2025. The company is expected to make a profit of AU$800.0k in 2026. Average annual earnings growth of 119% is required to achieve expected profit on schedule. Announcement • Jul 30
CleanSpace Holdings Limited, Annual General Meeting, Nov 28, 2025 CleanSpace Holdings Limited, Annual General Meeting, Nov 28, 2025. Announcement • Jul 15
CleanSpace Holdings Limited to Report Fiscal Year 2025 Results on Aug 26, 2025 CleanSpace Holdings Limited announced that they will report fiscal year 2025 results on Aug 26, 2025 Announcement • Jan 08
CleanSpace Holdings Limited Announces CEO Changes CleanSpace Holdings Limited confirmed that Ms. Gabrielle O'Carroll commenced as Chief Executive Officer (CEO) of the Company, effective 1 January 2025. Mr. Graham McLean stepped down as CEO as at 31 December 2024 and remains Chairman of the Board. He and the team are providing a smooth transition to Ms. O'Carroll. Mr. McLean's engagement arrangements have changed to that of Chairman only on the same terms and conditions as the previous Chair. Mr. Mclean will retain the Performance Rights awarded to him as CEO together with 37,000 unvested Restricted Stock Units. All incentives are subject to vesting conditions. 75,000 unvested RSUs have been forfeited. Reported Earnings • Aug 28
Full year 2024 earnings released Full year 2024 results: Revenue: AU$15.7m (up 30% from FY 2023). Net loss: AU$3.10m (loss narrowed 62% from FY 2023). Announcement • Aug 01
CleanSpace Holdings Limited, Annual General Meeting, Nov 11, 2024 CleanSpace Holdings Limited, Annual General Meeting, Nov 11, 2024. Announcement • Jul 16
CleanSpace Holdings Limited to Report Fiscal Year 2024 Results on Aug 27, 2024 CleanSpace Holdings Limited announced that they will report fiscal year 2024 results on Aug 27, 2024 Board Change • Sep 06
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. 2 independent directors (3 non-independent directors). Director of Innovation & Operations and Executive Director Dan Kao is the most experienced director on the board, commencing their role in 2011. Independent Non-Executive Director Lisa Hennessy was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Announcement • Aug 31
CleanSpace Holdings Limited Appoints Paul Cassano as Non-Executive Director , Effective 1 September 2023 CleanSpace Holdings Limited has continued its Board renewal with the appointment of Non-Executive Director (NED), Mr. Paul Cassano, effective 1 September 2023. Paul Cassano is an executive with over 30 years' industry experience in general management, operations management and technical roles in the mining and resources sectors with Downer, Thiess and BHP. Paul's wide experience includes 13 years at Downer, where he was most recently CEO Mining, 14 years at BHP in leadership and technical roles, and as EGM, Resources and Development Group at Thiess. Paul currently provides independent management consulting services as Managing Director of Resilient Resources Pty Ltd. He holds a Bachelor of Engineering in Mining from the University of Sydney and a Master of Business Administration (Executive) from the University of Queensland. He is a member of the Australian Institute of Mining and Metallurgy and the Australian Institute of Company Directors. Reported Earnings • Aug 30
Full year 2023 earnings released: AU$0.11 loss per share (vs AU$0.15 loss in FY 2022) Full year 2023 results: AU$0.11 loss per share (improved from AU$0.15 loss in FY 2022). Revenue: AU$12.1m (down 9.5% from FY 2022). Net loss: AU$8.13m (loss narrowed 28% from FY 2022). New Risk • Aug 23
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (AU$21.6m market cap, or US$13.9m). Announcement • Aug 01
Cleanspace Holdings Limited Announces Chief Financial Officer Changes CleanSpace Holdings Limited announced the appointment of a new Interim Chief Financial Officer ("CFO"). Ms Bree Greeff joined CleanSpace in May 2022 as Financial Controller and will step up into the Interim CFO role from 1 August 2023. She succeeds Ms Elizabeth Harvey who announced her resignation on 16 May 2023, with effect 28 August. Ms Harvey will complete the FY23 full year results prior to her departure. Ms Greeff has previously held finance management roles with Publicis (a creative solutions agency) for 6 years, J Melnick & Co (a diversified brand manager) for 5 years, as well as transport and mining companies, all in South Africa. She holds a B Compt degree in Accounting & Auditing and is a member of the Chartered Institute of Management Accountants (CIMA). New Risk • Jul 18
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Australian stocks, typically moving 17% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 39% per year over the past 5 years. Minor Risk Market cap is less than US$100m (AU$20.4m market cap, or US$13.9m). New Risk • Jun 27
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$14.6m (US$9.77m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (AU$14.6m market cap, or US$9.77m). Minor Risk Share price has been volatile over the past 3 months (14% average weekly change). Announcement • May 18
Cleanspace Holdings Limited Announces Resignation of Elizabeth Harvey as Joint Company Secretary CleanSpace Holdings Limited announced the resignation of Joint Company Secretary. Ms Elizabeth Harvey tendered her resignation as Joint Company Secretary of CleanSpace in order to pursue other interests. She will remain with the business as she serves out her 3-month notice period. Ms Harvey will continue as a committed and passionate shareholder. Ms Harvey has been with the business for over 5 years. In that time, the Company listed on ASX and experienced the extreme challenges of responding to the Covid pandemic fuelled demand for CleanSpace products and solutions. In more recent times, she has been instrumental in managing the rightsizing of the business. Ms Harvey will remain in her role through her notice period of 3 months, and during that time the Company will identify and announce a replacement CFO. Announcement • May 17
Cleanspace Holdings Limited Announces Resignation of Elizabeth Harvey as Chief Financial Officer CleanSpace Holdings Limited announced the resignation of the Chief Financial Officer (CFO). Ms Elizabeth Harvey tendered her resignation as Chief Financial Officer (CFO) of CleanSpace in order to pursue other interests. She will remain with the business as she serves out her 3-month notice period. Ms Harvey will continue as a committed and passionate shareholder. Ms Harvey has been with the business for over 5 years. In that time, the Company listed on ASX and experienced the extreme challenges of responding to the Covid pandemic fuelled demand for CleanSpace products and solutions. In more recent times, she has been instrumental in managing the rightsizing of thebusiness. Ms Harvey will remain in her role through her notice period of 3 months, and during that time the Company will identify and announce a replacement CFO. Reported Earnings • Feb 21
First half 2023 earnings released: AU$0.062 loss per share (vs AU$0.07 loss in 1H 2022) First half 2023 results: AU$0.062 loss per share (improved from AU$0.07 loss in 1H 2022). Revenue: AU$5.72m (down 19% from 1H 2022). Net loss: AU$4.74m (loss narrowed 12% from 1H 2022). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Medical Equipment industry in Australia. Announcement • Feb 13
CleanSpace Holdings Limited to Report First Half, 2023 Results on Feb 20, 2023 CleanSpace Holdings Limited announced that they will report first half, 2023 results on Feb 20, 2023 Board Change • Jan 18
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Non-Executive Director Lisa Hennessy was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jan 10
CleanSpace Holdings Limited Announces CEO Changes CleanSpace Holdings Limited announced a change of CEO. Dr. Alex Birrell has tendered her resignation as CEO of the company, so as to pursue other interests. She will remain with the business as she serves out her 3 month notice period. Dr. Birrell will continue as a committed and passionate shareholder. Mr. Graham McLean has been appointed by the Board to immediately step in as Interim CEO pending appointment of a permanent CEO. Mr. McLean is a very experienced senior executive having worked with NYSE-listed Stryker for 16-years and brings significant operational and healthcare experience. Stryker is a global company offering a range of products and services, including healthcare PPE, sold via distributors and direct sales. At Stryker, Mr. McLean held several senior positions, including President, Japan, President Australia/New Zealand and President, Asia Pacific, based in Singapore and Hong Kong. During this time, Mr. McClean was responsible for transforming Asia Pacific, including restructuring their China distribution to accelerate growth of the business, resulting in Asia Pacific becoming a fastest growing, multi-billion-dollar sales region. Mr. McLean holds a Bachelor of Science Geography from Durham University, is a CPA, a Fellow of The Chartered Institute of Management Accountants and a Graduate of the Australian Institute of Company Directors. He is currently an advisor to Bain & Company and GLG, Non-Exec Director at Universal Biosensors and a Suicide Prevention Australia board member. 
